If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

  • 5420 Citations
  • 31 h-Index
  • 175 Article
  • 2 Review article
2015
594 Citations (Scopus)

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma

ASPIRE Investigators, jan. 8 2015, In : New England Journal of Medicine. 372, 2, p. 142-152 11 p.

Research output: Article

Multiple Myeloma
Dexamethasone
Control Groups
Disease-Free Survival
Confidence Intervals
8 Citations (Scopus)

NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma

Varga, G., Mikala, G., Andrikovics, H., Koszarska, M., Balassa, K., Ádám, E., Kozma, A., Tordai, A. & Masszi, T., márc. 1 2015, In : British Journal of Haematology. 168, 5, p. 679-688 10 p.

Research output: Article

Multiple Myeloma
Disease-Free Survival
Alleles
NF-kappa B
Fluorescence In Situ Hybridization
14 Citations (Scopus)

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors

Khoury, H. J., Cortes, J., Baccarani, M., Wetzler, M., Masszi, T., Digumarti, R., Craig, A., Benichou, A. C. & Akard, L., jan. 1 2015, In : Leukemia and Lymphoma. 56, 1, p. 120-127 8 p.

Research output: Article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Cytogenetics
Leukemia, Myeloid, Accelerated Phase
Blast Crisis
32 Citations (Scopus)

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

Stone, R. M., Mazzola, E., Neuberg, D., Allen, S. L., Pigneux, A., Stuart, R. K., Wetzler, M., Rizzieri, D., Erba, H. P., Damon, L., Jang, J. H., Tallman, M. S., Warzocha, K., Masszi, T., Sekeres, M. A., Egyed, M., Horst, H. A., Selleslag, D., Solomon, S. R., Venugopal, P. & 2 others, Lundberg, A. S. & Powell, B., márc. 20 2015, In : Journal of Clinical Oncology. 33, 11, p. 1252-1257 6 p.

Research output: Article

amonafide
Daunorubicin
Cytarabine
Dilatation and Curettage
Acute Myeloid Leukemia
247 Citations (Scopus)

Ruxolitinib versus standard therapy for the treatment of polycythemia vera

Vannucchi, A. M., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Mesa, R., He, S., Jones, M. M., Garrett, W., Li, J., Pirron, U., Habr, D. & Verstovsek, S., jan. 1 2015, In : New England Journal of Medicine. 372, 5, p. 426-435 10 p.

Research output: Article

Polycythemia Vera
Hydroxyurea
Hematocrit
Therapeutics
Janus Kinase 1
87 Citations (Scopus)

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial

Pardanani, A., Harrison, C., Cortes, J. E., Cervantes, F., Mesa, R. A., Milligan, D., Masszi, T., Mishchenko, E., Jourdan, E., Vannucchi, A. M., Drummond, M. W., Jurgutis, M., Kuliczkowski, K., Gheorghita, E., Passamonti, F., Neumann, F., Patki, A., Gao, G. & Tefferi, A., aug. 1 2015, In : JAMA oncology. 1, 5, p. 643-651 9 p.

Research output: Article

Primary Myelofibrosis
Randomized Controlled Trials
Safety
Essential Thrombocythemia
Polycythemia Vera
126 Citations (Scopus)

Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., Blaise, D., Ciceri, F., Corbacioglu, S., Dalle, J. H., Duarte, R. F., Fukuda, T., Huynh, A., Masszi, T., Michallet, M., Nagler, A. & 10 others, Nichonghaile, M., Pagluica, T., Peters, C., Petersen, F. B., Richardson, P. G., Ruutu, T., Savani, B. N., Wallhult, E., Yakoub-Agha, I. & Carreras, E., jún. 4 2015, In : Bone Marrow Transplantation. 50, 6, p. 781-789 9 p.

Research output: Article

Hepatic Veno-Occlusive Disease
Transplantation
Bone Marrow
Biomarkers
Prospective Studies
11 Citations (Scopus)
Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
11 Citations (Scopus)
Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
11 Citations (Scopus)
Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
11 Citations (Scopus)
Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
11 Citations (Scopus)

The potential role of HLA-DRB1∗11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Szilvasi, A., Rajczy, K., Inotai, D., Gopcsa, L., Lengyel, L., Barta, A., Reti, M., Tordai, A. & Masszi, T., okt. 1 2015, In : Bone Marrow Transplantation. 50, 10, p. 1321-1325 5 p.

Research output: Article

Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
2014
63 Citations (Scopus)

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, C., Brümmendorf, T. H., Kim, D. W., Turkina, A. G., Masszi, T., Assouline, S., Durrant, S., Kantarjian, H. M., Khoury, H. J., Zaritskey, A., Shen, Z. X., Jin, J., Vellenga, E., Pasquini, R., Mathews, V., Cervantes, F., Besson, N., Turnbull, K., Leip, E., Kelly, V. & 1 others, Cortes, J. E., 2014, In : American Journal of Hematology. 89, 7, p. 732-742 11 p.

Research output: Article

Leukemia, Myeloid, Chronic Phase
Safety
Cytogenetics
Therapeutics
src-Family Kinases
Diffusion Magnetic Resonance Imaging
Plasmacytoma
Subclavian Artery
Multiple Myeloma
Neoplasms
59 Citations (Scopus)

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Andrikovics, H., Krahling, T., Balassa, K., Halm, G., Bors, A., Koszarska, M., Batai, A., Dolgos, J., Csomor, J., Egyed, M., Sipos, A., Remenyi, P., Tordai, A. & Masszi, T., júl. 1 2014, In : Haematologica. 99, 7, p. 1184-1190 7 p.

Research output: Article

Calreticulin
Janus Kinase 2
Essential Thrombocythemia
Mutation
Primary Myelofibrosis
4 Citations (Scopus)

Komplex molekuláris genetikai vizsgálati algoritmus myeloproliferativ neoplasiák diagnosztikájában

Krhling, T., Balassa, K., Meggyesi, N., Bors, A., Csomor, J., Bátai, Á., Halm, G., Egyed, M., Fekete, S., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., dec. 1 2014, In : Orvosi Hetilap. 155, 52, p. 2074-2081 8 p.

Research output: Article

Molecular Pathology
Calreticulin
Molecular Biology
Thrombopoietin Receptors
Mutation
4 Citations (Scopus)

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

Koszarska, M., Meggyesi, N., Bors, A., Batai, A., Csacsovszki, O., Lehoczky, E., Adam, E., Kozma, A., Lovas, N., Sipos, A., Krahling, T., Dolgos, J., Remenyi, P., Fekete, S., Masszi, T., Tordai, A. & Andrikovics, H., 2014, In : Leukemia and Lymphoma. 55, 7, p. 1510-1517 8 p.

Research output: Article

fms-Like Tyrosine Kinase 3
Acute Myeloid Leukemia
Disease-Free Survival
Survival
Multivariate Analysis
2 Citations (Scopus)

Mennyit vár ma Magyarországon egy myelomás beteg a diagnózisig?

Varga, G., Mikala, G., Andrikovics, H. & Masszi, T., szept. 1 2014, In : Orvosi Hetilap. 155, 39, p. 1538-1543 6 p.

Research output: Article

Hungary
Patient Identification Systems
Primary Care Physicians
Amyloidosis
Hematology
18 Citations (Scopus)

Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF

Reményi, P., Gopcsa, L., Marton, I., Réti, M., Mikala, G., Pető, M., Barta, A., Bátai, Á., Farkas, Z., Borbényi, Z., Csukly, Z., Bodó, I., Fábián, J., Király, Á., Lengyel, L., Piukovics, K., Torbágyi, É. & Masszi, T., ápr. 1 2014, In : Advances in Therapy. 31, 4, p. 451-460 10 p.

Research output: Article

Biosimilar Pharmaceuticals
Hematopoietic Stem Cell Mobilization
Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
Leukapheresis
30 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Treatment Failure
Cohort Studies
Confidence Intervals
Disease-Free Survival
2013
80 Citations (Scopus)

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.

Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., Socie, G., Sengelov, H., Michallet, M., Passweg, J., Veelken, H., Yakoub-Agha, I., Shimoni, A. & Mohty, M., okt. 1 2013, In : Journal of Clinical Oncology. 31, 28, p. 3549-3556 8 p.

Research output: Article

Busulfan
Whole-Body Irradiation
Hematopoietic Stem Cell Transplantation
Blood Group Antigens
Acute Myeloid Leukemia
9 Citations (Scopus)

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation

Janicsák, H., Masszi, T., Reményi, P., Ungvari, G. S. & Gazdag, G., aug. 2013, In : European Journal of Haematology. 91, 2, p. 135-140 6 p.

Research output: Article

Bone Marrow Transplantation
Quality of Life
Demography
Depression
Psychology
58 Citations (Scopus)

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

Ludwig, H., Viterbo, L., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Ricci, D., Cakana, A., Enny, C., Feng, H., Van De Velde, H. & Harousseau, J. L., jan. 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 247-255 9 p.

Research output: Article

Thalidomide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Stem Cell Transplantation
5 Citations (Scopus)
Treatment Failure
Multiple Myeloma
Bone Marrow Transplantation
Renal Insufficiency
Kidney
18 Citations (Scopus)

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

Koszarska, M., Bors, A., Feczko, A., Meggyesi, N., Batai, A., Csomor, J., Adam, E., Kozma, A., Orban, T. I., Lovas, N., Sipos, A., Karaszi, E., Dolgos, J., Fekete, S., Reichardt, J., Lehoczky, E., Masszi, T., Tordai, A. & Andrikovics, H., máj. 2013, In : Leukemia and Lymphoma. 54, 5, p. 1028-1035 8 p.

Research output: Article

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Mutation
Survival
Platelet Count
2012
5 Citations (Scopus)
Bone Marrow Transplantation
Keratinocytes
Tissue Donors
Biopsy
Skin
18 Citations (Scopus)

Characterization and function of histamine receptors in human bone marrow stromal cells

Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Búzás, E., Falus, A., Key, S., Masszi, T., Kárpáti, S. & Mezey, E., febr. 2012, In : Stem Cells. 30, 2, p. 222-231 10 p.

Research output: Article

Histamine Receptors
Mesenchymal Stromal Cells
Histamine
Interleukin-6
Artificial Cells
6 Citations (Scopus)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Computational Biology
Molecular Biology
Exons
Clonal Evolution
15 Citations (Scopus)

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis

Nicolini, F. E., Masszi, T., Shen, Z., Gallagher, N. J., Jootar, S., Powell, B. L., Dorlhiac-Llacer, P. E., Zheng, M., Szczudlo, T. & Turkina, A., máj. 2012, In : Leukemia and Lymphoma. 53, 5, p. 907-914 8 p.

Research output: Article

Leukemia, Myeloid, Accelerated Phase
Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Multicenter Studies
Clinical Trials
27 Citations (Scopus)

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T. & Kim, D. W., ápr. 2012, In : Leukemia Research. 36, 4, p. 438-442 5 p.

Research output: Article

Leukemia, Myeloid, Chronic Phase
Quality of Life
Leukemia
Therapeutics
Protein-Tyrosine Kinases
60 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Registries
Transplantation
Bone Marrow
14 Citations (Scopus)
Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
14 Citations (Scopus)
Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
14 Citations (Scopus)
Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
14 Citations (Scopus)
Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
14 Citations (Scopus)

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: Safety and efficacy data in a series of 21 patients from Europe and the USA

Douglas, K. W., Parker, A. N., Hayden, P. J., Rahemtulla, A., D'Addio, A., Lemoli, R. M., Rao, K., Maris, M., Pagliuca, A., Uberti, J., Scheid, C., Noppeney, R., Cook, G., Bokhari, S. W., Worel, N., Mikala, G., Masszi, T., Taylor, R. & Treisman, J., jan. 2012, In : Bone Marrow Transplantation. 47, 1, p. 18-23 6 p.

Research output: Article

Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
164 Citations (Scopus)

Superiority of the triple combination of bortezomib-thalidomide- dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: The MMVAR/IFM 2005-04 randomized phase III trial from the chronic leukemia working party of the European Group for blood and marrow transplantation

Garderet, L., Iacobelli, S., Moreau, P., Dib, M., Lafon, I., Niederwieser, D., Masszi, T., Fontan, J., Michallet, M., Gratwohl, A., Milone, G., Doyen, C., Pegourie, B., Hajek, R., Casassus, P., Kolb, B., Chaleteix, C., Hertenstein, B., Onida, F., Ludwig, H. & 10 others, Ketterer, N., Koenecke, C., Van Os, M., Mohty, M., Cakana, A., Gorin, N. C., De Witte, T., Harousseau, J. L., Morris, C. & Gahrton, G., júl. 10 2012, In : Journal of Clinical Oncology. 30, 20, p. 2475-2482 8 p.

Research output: Article

Thalidomide
Autologous Transplantation
Blood Group Antigens
Multiple Myeloma
Dexamethasone
2011
15 Citations (Scopus)

Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients

Meggyesi, N., Kozma, A., Halm, G., Nahajevszky, S., Bátai, Á., Fekete, S., Barta, A., Ujj, G., Lueff, S., Sipos, A., Ádám, E., Bors, A., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., dec. 2011, In : Acta Haematologica. 127, 1, p. 34-42 9 p.

Research output: Article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chromosome Aberrations
Protein-Tyrosine Kinases
Mutation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8 Citations (Scopus)

Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

Mohl, A., Boda, Z., Jager, R., Losonczy, H., Marosi, A., Masszi, T., Nagy, E., Nemes, L., Obser, T., Oyen, F., Radványi, G., Schlammadinger, Á., Szélessy, Z. S., Várkonyi, A., Vezendy, K., Vilimi, B., Schneppenheim, R. & Bodó, I., máj. 2011, In : Journal of Thrombosis and Haemostasis. 9, 5, p. 945-952 8 p.

Research output: Article

Type 3 Von Willebrand's Disease
Isoantibodies
Gene Deletion
von Willebrand Factor
Mutation
3 Citations (Scopus)

Gram-negatív bacteriaemia neutropeniás hematológiai betegekben. Tapasztalatok fluorokinolonprofilaxis alkalmazása kapcsán

Sinkó, J., Cser, V., Konkoly Thege, M. & Masszi, T., júl. 1 2011, In : Orvosi Hetilap. 152, 27, p. 1063-1067 5 p.

Research output: Article

Fluoroquinolones
Bacteremia
Mortality
Incidence
Stem Cell Transplantation
30 Citations (Scopus)

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Basic-Kinda, S., Mayer, J., Masszi, T., Giebel, S., Labar, B. & Wiktor-Jedrzejczak, W., jún. 2011, In : European Journal of Haematology. 86, 6, p. 488-495 8 p.

Research output: Article

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Stem Cells
Stem Cell Transplantation
20 Citations (Scopus)

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Mayer, J., Masszi, T., Labar, B. & Wiktor-Jedrzejczak, W., júl. 2011, In : American Journal of Hematology. 86, 7, p. 550-553 4 p.

Research output: Article

Hematopoietic Stem Cell Mobilization
Odds Ratio
Melphalan
Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
8 Citations (Scopus)

Lymphoid aggregates may contribute to the migration and epithelial commitment of Bone marrow-derived cells in colonic mucosa

Valcz, G., Krenács, T., Sípos, F., Patai, Á. V., Wichmann, B., Leiszter, K., Tóth, K., Balogh, Z., Csizmadia, A., Hagymási, K., Masszi, T., Molnár, B. & Tulassay, Z., szept. 2011, In : Journal of Clinical Pathology. 64, 9, p. 771-775 5 p.

Research output: Article

Bone Marrow Cells
Mucous Membrane
Colitis
Mesenchymal Stromal Cells
Fluorescent Antibody Technique
21 Citations (Scopus)
Hematopoietic Stem Cell Mobilization
Drug Therapy
Granulocyte Colony-Stimulating Factor
Leukocyte Count
Blood Cells
21 Citations (Scopus)

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: It's not too late

Basak, G. W., Mikala, G., Koristek, Z., Jaksic, O., Basic-Kinda, S., Cegledi, A., Reti, M., Masszi, T., Mayer, J., Giebel, S., Hbel, K., Labar, B. & Wiktor-Jedrzejczak, W., szept. 2011, In : Leukemia and Lymphoma. 52, 9, p. 1711-1719 9 p.

Research output: Article

Hematopoietic Stem Cell Mobilization
Drug Therapy
Granulocyte Colony-Stimulating Factor
Leukocyte Count
Blood Cells
3 Citations (Scopus)

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Györke, T., Kollár, A., Bottlik, G., Szepesi, Á., Bodó, I., Masszi, T., Bérczi, V. & Garai, I., ápr. 2011, In : International Journal of Hematology. 93, 4, p. 545-550 6 p.

Research output: Article

Hodgkin Disease
Lymph Nodes
Biopsy
Drug Therapy
Minimally Invasive Surgical Procedures
2010
18 Citations (Scopus)

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

Gézsi, A., Budde, U., Deák, I., Nagy, E., Mohl, A., Schlammadinger, Á., Boda, Z., Masszi, T., Sadler, J. E. & Bodó, I., jún. 2010, In : Journal of Thrombosis and Haemostasis. 8, 6, p. 1273-1280 8 p.

Research output: Article

von Willebrand Diseases
von Willebrand Factor
Half-Life
Theoretical Models
Deamino Arginine Vasopressin
8 Citations (Scopus)

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Skribek, H., Otvos, R., Flaberg, E., Nagy, N., Markasz, L., Eksborg, S., Masszi, T., Kozma, A., Adam, E., Miseta, A., Klein, E. & Szekely, L., dec. 2010, In : Experimental Hematology. 38, 12, p. 1219-1230 12 p.

Research output: Article

Lymphoid Leukemia
Epirubicin
Daunorubicin
Prednisolone
Doxorubicin
87 Citations (Scopus)

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: Efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily

Saglio, G., Hochhaus, A., Goh, Y. T., Masszi, T., Pasquini, R., Maloisel, F., Erben, P., Cortes, J., Paquette, R., Bradley-Garelik, M. B., Zhu, C. & Dombret, H., aug. 15 2010, In : Cancer. 116, 16, p. 3852-3861 10 p.

Research output: Article

Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Dasatinib
Philadelphia Chromosome